Sun Pharmaceutical Industries shares surged by 6.5 per cent today after one of its subsidiaries received USFDA approval to manufacture and market generic version of Novartis’ Gleevec, used in the…
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
